Procter & Gamble (NYSE:PG - Get Free Report) had its target price boosted by investment analysts at Piper Sandler from $160.00 to $164.00 in a research note issued on Monday,Benzinga reports. The firm currently has a "neutral" rating on the stock. Piper Sandler's target price would suggest a potential upside of 3.55% from the stock's previous close.
Several other analysts have also recently commented on the company. Citigroup decreased their target price on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a report on Friday, April 25th. UBS Group reaffirmed a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. JPMorgan Chase & Co. lowered their target price on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. DA Davidson reiterated a "buy" rating and issued a $209.00 price objective on shares of Procter & Gamble in a research report on Thursday, January 23rd. Finally, Bank of America lowered their price target on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Eight investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $179.40.
View Our Latest Report on Procter & Gamble
Procter & Gamble Price Performance
Shares of Procter & Gamble stock traded down $2.15 during trading on Monday, hitting $158.37. 2,304,150 shares of the company's stock traded hands, compared to its average volume of 7,145,563. The company has a market cap of $371.31 billion, a PE ratio of 25.20, a PEG ratio of 3.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. Procter & Gamble has a twelve month low of $156.58 and a twelve month high of $180.43. The firm's fifty day moving average price is $167.36 and its 200 day moving average price is $167.93.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.01. The firm had revenue of $19.78 billion for the quarter, compared to analysts' expectations of $20.42 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business's revenue was down 2.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.52 earnings per share. Analysts forecast that Procter & Gamble will post 6.91 earnings per share for the current year.
Insiders Place Their Bets
In related news, CEO Jennifer L. Davis sold 1,000 shares of the firm's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer now directly owns 51,965 shares in the company, valued at approximately $8,386,111.70. This trade represents a 1.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Gary A. Coombe sold 18,000 shares of the business's stock in a transaction that occurred on Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total value of $3,089,880.00. Following the transaction, the chief executive officer now directly owns 22,051 shares in the company, valued at approximately $3,785,274.66. This trade represents a 44.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 54,000 shares of company stock valued at $9,330,060 in the last 90 days. 0.18% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of PG. Lakeridge Wealth Management LLC increased its position in Procter & Gamble by 0.6% during the fourth quarter. Lakeridge Wealth Management LLC now owns 10,807 shares of the company's stock worth $1,812,000 after acquiring an additional 60 shares during the period. Unique Wealth LLC raised its position in shares of Procter & Gamble by 2.9% in the first quarter. Unique Wealth LLC now owns 2,141 shares of the company's stock valued at $365,000 after buying an additional 61 shares in the last quarter. Stableford Capital II LLC increased its stake in Procter & Gamble by 1.1% during the 1st quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock worth $993,000 after acquiring an additional 61 shares during the period. Colton Groome Financial Advisors LLC grew its holdings in shares of Procter & Gamble by 3.2% during the 4th quarter. Colton Groome Financial Advisors LLC now owns 1,995 shares of the company's stock worth $334,000 after purchasing an additional 62 shares in the last quarter. Finally, Bernard Wealth Management Corp. lifted its position in Procter & Gamble by 20.2% during the first quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock worth $64,000 after purchasing an additional 63 shares during the period. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Company Profile
(
Get Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.